Suchergebnisse - "Oyagawa, Caitlin R. M."

PubPharm (7)

1

Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate

enthalten in: Cell communication and signaling : CCS | 2024

von Cooper, E. | Oyagawa, C. | Johnson, R. | +12

2

Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate

enthalten in: Cell communication and signaling | 2024

von Cooper, E. | Oyagawa, C. | Johnson, R. | +12

3

Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid α/β-Hydrolase Domain 6 (ABHD6)

enthalten in: Journal of medicinal chemistry | 2023

von Mardon, K. | Patel, J. | Savinainen, J. | +16

4

Cannabinoid receptor CB1 and CB2 interacting proteins : Techniques, progress and perspectives

enthalten in: Methods in cell biology | 2021

von Oyagawa, C. | Grimsey, N.

5

Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor

enthalten in: ACS medicinal chemistry letters | 2019

von Singh, S. | Oyagawa, C. | Macdonald, C. | +3

6

Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold

enthalten in: MedChemComm | 2018

von Cooper, A. | Oyagawa, C. | Manning, J. | +6

7

Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines

enthalten in: Frontiers in pharmacology | 2018

von Oyagawa, C. | de la Harpe, S. | Saroz, Y. | +3

ErratumIn: Front Pharmacol. 2019 Apr 05;10:418. - PMID 31024325

1
[1]